EVEREST MED: CBC Group and Honorary Chairman Wei Fu Add 679,000 Shares for HK$18.90 Million

Bulletin Express
Jun 10

Everest Medicines Limited (EVEREST MED) announced that substantial shareholder CBC Group, acting in concert with non-executive director and honorary chairman Wei Fu, purchased 679,000 ordinary shares on the open market between 8 June 2026 and 9 June 2026.

The transaction amounted to approximately HK$18.90 million, translating to an average acquisition price of HK$27.90 per share.

According to the filing, the additional stake reflects CBC Group’s and Wei Fu’s confidence in the company’s long-term prospects. The parties indicated that further share purchases may be considered, subject to regulatory compliance.

The board advised shareholders and potential investors to exercise caution when dealing in the company’s securities. The voluntary announcement was released on 10 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10